| Completed | Clinical Evaluation of Long-term Sequelae in Patients With Severe Plasmodium Falciparum Malaria NCT06992297 | Assistance Publique Hopitaux De Marseille | N/A |
| Recruiting | A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of t NCT05911828 | Zydus Lifesciences Limited | Phase 1 |
| Recruiting | The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Ther NCT06347471 | Infectious Diseases Research Collaboration, Uganda | Phase 4 |
| Recruiting | Malaria Molecular Surveillance in Mozambique (Phase 2) NCT06529237 | Centro de Investigacao em Saude de Manhica | — |
| Withdrawn | Nitrite Infusion in Children With Malaria NCT04289558 | Duke University | Phase 1 |
| Unknown | Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Came NCT04829695 | University of Yaounde 1 | Phase 4 |
| Completed | Biological Mechanisms in Afebrile P. Falciparum Malaria NCT04422015 | Alfredo Mayor | — |
| Completed | Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas NCT03916003 | Menzies School of Health Research | Phase 4 |
| Completed | TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014 NCT04222088 | Research Institute for Tropical Medicine, Philippines | — |
| Completed | Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uga NCT01365598 | London School of Hygiene and Tropical Medicine | Phase 3 |
| Completed | Azithromycin Combination Therapy for the Treatment of Severe Malaria NCT01374126 | Medical University of Vienna | Phase 2 |
| Completed | Tracking Resistance to Artemisinin (TRAC) NCT01350856 | University of Oxford | Phase 4 |
| Completed | Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium Falciparu NCT01144702 | Oswaldo Cruz Foundation | Phase 2 / Phase 3 |
| Completed | Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria NCT01115439 | University of Oxford | — |
| Completed | Efficacy of ArTiMist™ in Children NCT01047436 | Proto Pharma Ltd | Phase 2 |
| Completed | A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) I NCT00894660 | Pfizer | Phase 1 |
| Completed | Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects NCT00894374 | Pfizer | Phase 1 |
| Completed | A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Heal NCT00859807 | Pfizer | Phase 4 |
| Completed | Artemisinin Resistance in Cambodia II NCT00722150 | Armed Forces Research Institute of Medical Sciences, Thailand | N/A |
| Completed | Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania NCT00513669 | Swiss Tropical & Public Health Institute | Phase 1 |
| Completed | Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia NCT00493363 | University of Oxford | N/A |
| Completed | Phase II Dose Ranging Study of Artesunate NCT00459615 | U.S. Army Office of the Surgeon General | Phase 2 |
| Completed | Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients NCT00403260 | Medicines for Malaria Venture | Phase 3 |
| Completed | Study to Investigate the Induction of an Protective Immune Response to Malaria NCT00442377 | Radboud University Medical Center | N/A |
| Completed | The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance NCT00440752 | Tropical Medicine Research Institute | — |
| Completed | A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Ma NCT00282919 | Pfizer | Phase 2 |
| Completed | Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria NCT00149383 | Mahidol University | Phase 1 / Phase 2 |
| Completed | A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia. NCT00157833 | Menzies School of Health Research | N/A |
| Completed | To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, Indonesia NCT00157859 | Menzies School of Health Research | N/A |
| Terminated | Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides NCT00400101 | Swiss Tropical & Public Health Institute | Phase 1 |
| Completed | ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan NCT00158548 | London School of Hygiene and Tropical Medicine | Phase 3 |